Fig. 6
SALL4 mediates the inhibition of SHP2 through the DOT1L/H3K79me2 signaling pathway in myocardial fibroblasts, thereby promoting the YAP/TAZ signaling pathway and contributing to the progression of myocardial infarction.
Fig. 6 | Scientific Reports
